from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2573/-

LFCtreatmentdescriptionclass of inhibitor

0.229

Amikacinug/mL Amikacintranslation

0.413

Cap5-10ug/mL Capreomycintranslation

2.653

Rox10-50 ug/mL Roxithromycintranslation

0.168

SM2-5 ug/mL Streptomycintranslation

0.967

Tet5-10 ug/mL Tetracyclinetranslation

0.851

Rif0.2-5ug/mL Rifampicintranscription

-0.450

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.864

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.623

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.667

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.076

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.051

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.633

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.199

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.047

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.407

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.509

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.907

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.135

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.537

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.061

KCN5-20 ug/mL Potassium cyaniderespiration

-0.376

NaN30.2-2 mM Sodium aziderespiration

-0.452

Nigericin50 uM Nigericinrespiration

-0.383

TRC10-150 ug/mL Triclosanrespiration

-0.157

TRZ10-25 ug/mL Thioridazinerespiration

-0.019

Valinomycin0.5-10 uM Valinomycinrespiration

0.797

ZnSO42 mM ZnSO4respiration

-0.677

menadione6-10 ug/mL Menadionerespiration

-0.264

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.499

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.814

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.016

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.394

NRP_1Non-replicating persistence stage 1dosRassociated

0.749

Amp0.2mg/mL AmpicillincellWall

0.283

Cephalexin20-100 ug/mL CephalexincellWall

0.086

Cerulenin0.32-5 ug/mL CerulenincellWall

1.105

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.036

EMB10-20 ug/mL EthambutolcellWall

0.951

Eta12-40 ug/mL EthionamidecellWall

1.192

INH0.2-0.4 ug/mL IsoniazidcellWall

0.883

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.608

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.818

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.880

BZA0.12 mg/mL BenzamidearomaticAmides

-0.199

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.013

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.571

H2O24 mM hydrogen peroxideDNAdamaging

-0.077

Levo10 ug/mL LevofloxacinDNAdamaging

0.062

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.699

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.739

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.913

UVUV-irradiationDNAdamaging

1.635

ARP41-4 ug/mL Antitubercular compound ARP4?

0.616

Antimycin12.5-50 ug/mL Antimycin A?

-0.260

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.910

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.072

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.380

PA8240.2-2 ug/mL PA-824?

-0.649

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.138

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.485

Verapamil50 uM Verapamil?

-0.476

mercaptoethanol2 mM 2-Mercaptoethanol?

0.245

methoxatin10-20 ug/mL Methoxatin?